Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.47
-0.02 (-0.31%)
May 2, 2025, 4:00 PM EDT - Market closed
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $560.14 million as of May 2, 2025. Its market cap has decreased by -60.43% in one year.
Market Cap
560.14M
Enterprise Value
-78.70M
1-Year Change
-60.43%
Ranking
Category
Stock Price
$6.47
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $560.14M, an increase of 392.65%. That is a compound annual growth rate of 18.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2025 | 561.90M | -17.04% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.17B |
| Johnson & Johnson | 374.41B |
| UnitedHealth Group | 359.36B |
| AbbVie | 345.75B |
| Novo Nordisk | 298.09B |
| Abbott Laboratories | 230.77B |
| Novartis AG | 223.05B |
| AstraZeneca | 218.59B |